Sponsor
Expres2ion Biotechnologies ApS
Agern Alle 1, 2970, Denmark
About the sponsor
Clinical research in HER2-positive metastatic breast cancer with a focus on patients receiving HER2 maintenance therapy, including disease that is metastatic or locally advanced and unresectable.
- HER2 expression
- Maintenance treatment
- Advanced breast cancer
- Unresectable disease
The sponsor’s research interest centers on oncology, particularly disease settings where HER2-targeted approaches remain clinically relevant.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.